ScinoPharm Taiwan Ltd (1789) — Cash Flow Reinvestment Rate
ScinoPharm Taiwan Ltd (1789) has a Cash Flow Reinvestment Rate of 0.24x as of December 2025, reinvesting NT$82.01 Million (capex NT$82.01 Million ) from operating cash flow of NT$343.96 Million. Explore 1789 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ScinoPharm Taiwan Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ScinoPharm Taiwan Ltd across 19 annual periods. Also explore 1789 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year capital reinvestment analysis for ScinoPharm Taiwan Ltd. For live market cap and broader valuation context, see ScinoPharm Taiwan Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.42x | NT$1.45 Billion | NT$597.11 Million | NT$291.29 Million | ▲ +529.6% |
| 2024 | 0.38x | NT$288.73 Million | NT$750.91 Million | NT$288.73 Million | ▼ -82.8% |
| 2023 | 2.24x | NT$518.00 Million | NT$231.13 Million | NT$284.71 Million | ▲ +244.3% |
| 2022 | 0.65x | NT$503.66 Million | NT$773.79 Million | NT$250.04 Million | ▼ -43.1% |
| 2021 | 1.14x | NT$582.83 Million | NT$509.82 Million | NT$321.32 Million | ▲ +69.6% |
| 2020 | 0.67x | NT$637.86 Million | NT$946.31 Million | NT$183.10 Million | ▲ +354.8% |
| 2019 | 0.15x | NT$116.94 Million | NT$788.95 Million | NT$105.70 Million | ▼ -39.6% |
| 2018 | 0.25x | NT$302.37 Million | NT$1.23 Billion | NT$127.05 Million | ▼ -45.5% |
| 2017 | 0.45x | NT$437.94 Million | NT$971.71 Million | NT$410.93 Million | ▲ +13.6% |
| 2016 | 0.40x | NT$660.84 Million | NT$1.67 Billion | NT$458.52 Million | ▼ -56.4% |
| 2015 | 0.91x | NT$951.79 Million | NT$1.04 Billion | NT$667.58 Million | ▼ -38.1% |
| 2014 | 1.47x | NT$1.31 Billion | NT$888.29 Million | NT$1.02 Billion | ▲ +2.3% |
| 2013 | 1.44x | NT$1.35 Billion | NT$939.47 Million | NT$1.24 Billion | ▲ +60.3% |
| 2012 | 0.90x | NT$881.19 Million | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$810.14 Million | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$405.62 Million | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$191.28 Million | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$144.62 Million | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$82.74 Million | NT$504.50 Million | NT$82.74 Million | — |